BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 1723674)

  • 21. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
    Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytological localization of hPL, hCG, and mRNA in chorionic tissue using in situ hybridization].
    Hoshina M; Boime I; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Mar; 36(3):397-404. PubMed ID: 6715923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of beta-hCG and human placental lactogen in serum of normal pregnancies and patients with pregnancy induced hypertension].
    Feng Q; Cui S; Yang W
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):648-50. PubMed ID: 11218889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
    Tangtakul S; Srisupundit S
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
    Hoshina M; Hussa R; Pattillo R; Boime I
    J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN; Bohn H; Csaba IF; Szabó DG; Karg NJ; Göcze P
    Arch Gynecol; 1981; 231(1):33-9. PubMed ID: 6174083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
    Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of the new placental proteins in trophoblastic disease.
    Tsakok FH; Koh S; Chua SE; Ratnam SS; Teisner B; Jones GR; Sinosich M; Grudzinskas JG
    Br J Obstet Gynaecol; 1983 May; 90(5):483-6. PubMed ID: 6189512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reference values for progesterone, beta-HCG, estriol and human placental lactogen in the 10th-16th weeks of pregnancy].
    Voss P; Linneke P; Haller G; Jeske W
    Zentralbl Gynakol; 1989; 111(13):897-903. PubMed ID: 2477968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.